Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication
 
HOUSE OF COMMONS   CHAMBRE DES COMMUNES
2nd Session, 39th Parliament   2e Session, 39e législature
 
NOTICE OF MEETING   AVIS DE CONVOCATION
 
Standing Committee on Health   Comité permanent de la santé
 
Meeting No. 9 Séance no 9
Thursday, January 31, 2008 Le jeudi 31 janvier 2008
11:00 a.m. to 1:00 p.m. 11 heures à 13 heures
Room 237-C, Centre Block   Pièce 237-C, édifice du Centre
(613-943-1496)   (613-943-1496)
 
  
 
Orders of the Day   Ordre du jour
 
 
Post-Market Surveillance of Pharmaceutical Products Surveillance post-commercialisation des produits pharmaceutiques
 
Panel on Federal Regulatory Authority Groupe d'experts sur l'organisme fédéral de réglementation
 
Witnesses Témoins
 
Department of Health ministère de la Santé
 
Meena Ballantyne, Assistant Deputy Minister
Health Products and Food Branch		 Meena Ballantyne, sous-ministre adjointe
Direction générale des produits de santé et des aliments
 
Diana Dowthwaite, Director General
Health Products and Food Branch Inspectorate		 Diana Dowthwaite, directrice générale
Inspectorat de la Direction générale des produits de santé et des aliments
 
Chris Turner, Director General
Marketed Health Products Directorate		 Chris Turner, directeur général
Direction des produits de santé commercialisés
 
Michael Vandergrift, Director General
Policy, Planning and International Affairs Directorate		 Michael Vandergrift, directeur général
Direction des politiques, de la planification et des affaires internationales
 
David K. Lee, Director
Office of Patented Medicines and Liaison, Therapeutic Products Directorate		 David K. Lee, directeur
Bureau des médicaments brevetés et de la liaison, Direction des produits thérapeutiques
 
 
La greffière du Comité
Carmen DePape ((613) 995-4108)
Clerk of the Committee
 
2008/01/25 1:57 p.m.   2008/01/25 13 h 57